EC grants marketing authorisation for GSK’s RSV vaccine Arexvy
The European Commission (EC) has granted marketing authorisation for GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, for adults aged 60…
The European Commission (EC) has granted marketing authorisation for GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, for adults aged 60…
A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and…
The University of Sydney and Australian company Pharos Therapeutics have reached an agreement to leverage artificial intelligence (AI) to progress…
Scientists at the Northwestern University in Illinois, US, have discovered a non-invasive approach to isolate a tumour’s attack cells from…
The Michigan Institute for Clinical and Health Research (MICHR) at the University of Michigan (U-M) has received a $71m grant…
The US government is reportedly investing more than $5bn in a programme to accelerate the development of new Covid-19 vaccines…
The US Department of Justice (DOJ) has filed an appeal challenging a Texas court ruling suspending the US Food and…
The US Food and Drug Administration (FDA) has rescinded its approval for Swiss drug maker Covis Pharma's (Covis) Makena drug…
Economists believe that the $1.9tn stimulus bill passed by the US Congress will enable the state and local governments to…
Merck has signed a strategic collaboration agreement with Skyhawk Therapeutics to use its SkySTAR technology to develop drug candidates for…